Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
01 1METHYLPREDNISOLONE ACETATE
01 1France
01 1Active
01 1Complete
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : Complete
Rev. Date : 2025-10-01
Pay. Date : 2025-09-29
DMF Number : 3452
Submission : 1979-02-08
Status : Active
Type : II
20
Euroapi France, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is METHYLPREDNISOLONE ACETATE, with a corresponding US DMF Number 3452.
Remarkably, this DMF maintains an Active status since its submission on February 08, 1979, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 01, 2025, and payment made on September 29, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
